Incretins: cardiovascular safety and rationale for use

Cardiovasc J Afr. 2013 Mar;24(2):46.
No abstract available

MeSH terms

  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control*
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Drug Therapy, Combination
  • Humans
  • Hypoglycemic Agents / adverse effects
  • Hypoglycemic Agents / therapeutic use*
  • Incretins / adverse effects
  • Incretins / therapeutic use*
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome

Substances

  • Hypoglycemic Agents
  • Incretins